查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405848

細胞膜穿透勝胜肽市場規模、佔有率、趨勢分析報告：按類型、應用、最終用途、地區和細分市場預測，2024-2030

Cell Penetrating Peptide Market Size, Share & Trends Analysis Report By Type, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

細胞膜穿透勝胜肽市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球細胞膜穿透勝胜肽市場規模將達到28.5億美元，2024年至2030年複合年成長率為10.08%。

對標靶給藥方法的需求不斷成長是推動成長的主要因素。化學修飾策略和胜肽合成技術的技術進步，以及引入精確治療劑的研發活動的活性化，正在增加對細胞膜穿透勝胜肽的市場需求。

此外，基於CPP技術的新藥核准正在增加，預計將在調查期間為主要參與者提供利潤豐厚的機會。例如，2022年9月，Revance Therapeutics, Inc.的DAXXIFY獲得美國食品藥物管理局核准，該藥物基於細胞穿透技術開發，用於暫時改善重度至中度鬢角。這項核准預計將促進市場成長。

胜肽生產過程的進步預計將推動市場的發展。製造商和供應商正致力於開發合成勝胜肽的新方法，例如細胞膜穿透勝胜肽。精製製程的改進和自動化以及減少廢棄物的產生進一步增加了各種應用對 CPP 的需求。例如，2022年3月，Creative Peptides宣布推出創新勝胜肽藥物研發服務，以加速胜肽療法的開發，包括CPP療法。

開拓利用細胞膜穿透勝胜肽治療多種疾病的新藥的資金開發預計將為市場相關人員開闢新的途徑。例如，2022年9月，凱克研究生院從天使症候群治療基金會獲得了為期兩年的50萬美元研究津貼，用於支持針對天使症候群的CPP的研究工作。諸如此類的措施正在支持細胞膜穿透勝胜肽領域的發展。

然而，雖然細胞膜穿透勝胜肽當然可以在撐體上手動合成，但這些是費力且耗時的。新系統的設備成本從 30,000 美元到超過 200,000 美元不等，具體取決於合成規模和軟體。因此，製造設備的高成本可能會阻礙小型公司和新興經濟體對細胞膜穿透勝胜肽的開發。同時，持續的技術進步可能會在預測期內推動CPP的應用。

細胞膜穿透勝胜肽市場報告亮點：

  • 按類型分類，合成 CPP 細分市場由於其在提供藥物、顯像劑和核酸等治療分子方面的獨特特性，將在 2023 年佔據市場主導地位。
  • 從應用來看，藥物遞送領域由於毒性低且向目標細胞遞送效率高，將在2023年佔據最大的市場佔有率。
  • 按最終用途分類，製藥和生物技術公司將在 2023 年引領市場。這是由於製藥和生物技術公司在研發活動以及新診斷和治療藥物的生產中擴大使用胜肽。
  • 由於細胞膜穿透勝胜肽研究資金的增加、有利的政府政策、技術進步以及該地區主要營運商的存在，北美已經建立了強大的區域地位和最高的市場佔有率。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 市場促進因素
    • 胜肽合成技術的進展
    • 靶向藥物傳輸的需求不斷成長
    • 存在強大的管道
  • 市場抑制因素分析
    • 胜肽複雜度增加
    • 製造設備成本高
  • 營商環境分析
    • SWOT 分析；按因素（政治/法律、經濟/技術）
    • 波特五力分析
    • COVID-19感染疾病的影響分析

第 4 章業務分析的類型

  • 細胞膜穿透勝胜肽市場：類型變異分析
  • 源自蛋白質的 CPP
  • 合成CPP
  • 嵌合體CPP

第 5 章應用程式的商業分析

  • 細胞膜穿透勝胜肽市場：應用變異分析
  • 藥物輸送
  • 基因轉移
  • 診斷
  • 分子影像
  • 其他

第 6 章最終用途業務分析

  • 細胞膜穿透勝胜肽市場：最終用途變異分析
  • 製藥和生物技術公司
  • 合約研究組織（CRO）
  • 醫院和診所
  • 其他

第7章 區域業務分析

  • 2023年及2030年細胞膜穿透勝胜肽依地區市場佔有率
  • 北美洲
    • 2018-2030年北美細胞膜穿透勝胜肽市場
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030年歐洲細胞膜穿透勝胜肽市場
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太細胞穿膜勝胜肽市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲細胞膜穿透勝胜肽市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • MEA細胞膜穿透勝胜肽市場，2018-2030年
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭形勢

  • 參與企業概況
  • 財務績效
  • 參與企業
    • 市場領導者
    • 2023年細胞膜穿透勝胜肽市場佔有率分析
    • 公司簡介
    • 策略規劃
Product Code: GVR-4-68040-167-1

Cell Penetrating Peptide Market Growth & Trends:

The global cell penetrating peptide market size is expected to reach USD 2.85 billion by 2030, expandingat a CAGR of 10.08% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing demand for targeted drug delivery methods is the primary factor propelling the growth. Technological advancements in chemical modification strategies & peptide synthesis techniques and increasing R&D activities to introduce precise therapeutics are increasing the demand for cell penetrating peptides in the market.

Moreover, rising approvals of novel drugs based on CPP technology is expected to offer lucrative opportunities for the key players during the study period. For instance, in September 2022, Revance Therapeutics, Inc. received U.S. Food and Drug Administration approval for DAXXIFY, which is developed based on cell-penetrating technology for temporary improvement of severe to moderate frown lines. This approval is projected to boost the market growth.

Advancements in the production processes of peptides are expected to drive the market. Manufacturers and suppliers are focused on developing new methods for synthesizing peptides, such as cell penetrating peptides. Improvement and automation of the purification process and lower waste generation are further increasing the demand for CPPs in different applications. For instance, in March 2022, Creative Peptides introduced innovative peptide drug discovery services to speed the development of peptide therapeutics, including CPPs therapies.

Growing funding for developing novel drugs to treat numerous diseases using cell penetrating peptides is anticipated to open new avenues for the market stakeholders. For instance, in September 2022, the Keck Graduate Institute received a research grant of USD 500,000 from the Foundation for Angelman Syndrome Therapeutics for two years to support research activities related to CPPs to targetAngelman Syndrome. Such initiatives are boosting the cell penetrating peptide sector growth.

However, cell penetrating peptides can certainly be synthesized on solid support using manual methods, and these can be tedious and time-intensive. The equipment for new systems can cost from USD 30,000 to USD 200,000 and above, depending on the synthesis scale capability & software. Hence, the high cost of manufacturing equipment may hamper the development of cell penetrating peptides by small players and emerging economies. On the other hand, continuous technological advancements are likely to boost the applications of CPPs during the forecast period.

Cell Penetrating Peptide Market Report Highlights:

  • Based on type, the synthetic CPPs segment dominated the market in 2023 owing to their intrinsic property of delivering therapeutic molecules such as drugs, imaging agents, and nucleic acids
  • Based on application, the drug delivery segment held the largest segment share of the market in 2023, attributable to their low toxicity and efficiency of drug delivery into target cells
  • Based on end-use, the pharmaceutical & biotechnology companies segment led the market in 2023. It can be attributed to the rising utilization of peptides in pharmaceutical and biotechnology companies for R&D activities and the production of novel diagnostics and therapeutics
  • North America has established a strong regional position with a highest market share owing to the increasing funding for cell penetrating peptide research, favorable government policies, technological advancements, and the presence of key operating players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. List Of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type, Application, and End-use Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Technological Advancements of Peptide Synthesis
    • 3.4.2. Growing Demand for Targeted Drug Delivery
    • 3.4.3. Presence of Strong Pipeline
  • 3.5. Market Restraint Analysis
    • 3.5.1. Increasing Complexity of Peptides
    • 3.5.2. High Cost of Manufacturing Equipment
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Cell Penetrating Peptide market: Type Movement Analysis
  • 4.2. Protein Derived CPPs
    • 4.2.1. Protein Derived CPPs Market, 2018 - 2030 (USD Million)
  • 4.3. Synthetic CPPs
    • 4.3.1. Synthetic CPPs Market, 2018 - 2030 (USD Million)
  • 4.4. Chimeric CPPs
    • 4.4.1. Chimeric CPPs Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Cell Penetrating Peptide Market: Application Movement Analysis
  • 5.2. Drug Delivery
    • 5.2.1. Drug Delivery Market, 2018 - 2030 (USD Million)
  • 5.3. Gene Delivery
    • 5.3.1. Gene Delivery Market, 2018 - 2030 (USD Million)
  • 5.4. Diagnostics
    • 5.4.1. Diagnostics Market, 2018 - 2030 (USD Million)
  • 5.5. Molecular Imaging
    • 5.5.1. Molecular Imaging Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Cell Penetrating Peptide Market: End-use Movement Analysis
  • 6.2. Pharmaceutical and Biotechnology Company
    • 6.2.1. Pharmaceutical and Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.3. Contract Research Organizations (CROs)
    • 6.3.1. Contract Research Organizations (CROs) Market, 2018 - 2030 (USD Million)
  • 6.4. Hospitals and Clinics
    • 6.4.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Cell Penetrating Peptide Market Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Target Disease Prevalence
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. Regulatory Framework
      • 7.2.2.5. Reimbursement Scenario
      • 7.2.2.6. U.S. Cell Penetrating Peptide market, 2018 - 2030 (USD MILLION)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. Canada Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. Reimbursement Scenario
      • 7.3.2.6. Germany Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. UK Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. France Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. Italy Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Spain Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Denmark Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Sweden Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Norway Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. Reimbursement Scenario
      • 7.4.2.6. Japan Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. China Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. India Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. South Korea Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. Australia Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Thailand Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Reimbursement Scenario
      • 7.5.2.6. Brazil Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Mexico Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Reimbursement Scenario
      • 7.5.4.6. Argentina Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. Reimbursement Scenario
      • 7.6.2.6. South Africa Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. Saudi Arabia Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. UAE Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. Kuwait Cell Penetrating Peptide market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant's overview
  • 8.2. Financial performance
  • 8.3. Participant categorization
    • 8.3.1. Market Leaders
    • 8.3.2. Cell Penetrating Peptide market Share Analysis, 2023
    • 8.3.3. Company Profiles
      • 8.3.3.1. Pepscan
      • 8.3.3.1.1. Company Overview
      • 8.3.3.1.2. Financial Performance
      • 8.3.3.1.3. Product Benchmarking
      • 8.3.3.1.4. Strategic Initiatives
      • 8.3.3.2. Creative Peptides
      • 8.3.3.2.1. Company Overview
      • 8.3.3.2.2. Financial Performance
      • 8.3.3.2.3. Product Benchmarking
      • 8.3.3.2.4. Strategic Initiatives
      • 8.3.3.3. Cupidpeptides
      • 8.3.3.3.1. Company Overview
      • 8.3.3.3.2. Financial Performance
      • 8.3.3.3.3. Product Benchmarking
      • 8.3.3.3.4. Strategic Initiatives
      • 8.3.3.4. AltaBioscience Ltd
      • 8.3.3.4.1. Company Overview
      • 8.3.3.4.2. Financial Performance
      • 8.3.3.4.3. Product Benchmarking
      • 8.3.3.4.4. Strategic Initiatives
      • 8.3.3.5. AnaSpec
      • 8.3.3.5.1. Company Overview
      • 8.3.3.5.2. Financial Performance
      • 8.3.3.5.3. Product Benchmarking
      • 8.3.3.5.4. Strategic Initiatives
      • 8.3.3.6. Peptomyc
      • 8.3.3.6.1. Company Overview
      • 8.3.3.6.2. Financial Performance
      • 8.3.3.6.3. Product Benchmarking
      • 8.3.3.6.4. Strategic Initiatives
      • 8.3.3.7. BioAlps
      • 8.3.3.7.1. Company Overview
      • 8.3.3.7.2. Financial Performance
      • 8.3.3.7.3. Product Benchmarking
      • 8.3.3.7.4. Strategic Initiatives
      • 8.3.3.8. Sarepta Therapeutics, Inc.
      • 8.3.3.8.1. Company Overview
      • 8.3.3.8.2. Financial Performance
      • 8.3.3.8.3. Product Benchmarking
      • 8.3.3.8.4. Strategic Initiatives
      • 8.3.3.9. REVANCE THERAPEUTICS
      • 8.3.3.9.1. Company Overview
      • 8.3.3.9.2. Financial Performance
      • 8.3.3.9.3. Product Benchmarking
      • 8.3.3.9.4. Strategic Initiatives
      • 8.3.3.10. Polypeptide Group
      • 8.3.3.10.1. Company Overview
      • 8.3.3.10.2. Financial Performance
      • 8.3.3.10.3. Product Benchmarking
      • 8.3.3.10.4. Strategic Initiatives
      • 8.3.3.11. Bachem
      • 8.3.3.11.1. Company Overview
      • 8.3.3.11.2. Financial Performance
      • 8.3.3.11.3. Product Benchmarking
      • 8.3.3.11.4. Strategic Initiatives
    • 8.3.4. Strategy Mapping
      • 8.3.4.1. Expansion
      • 8.3.4.2. Acquisition
      • 8.3.4.3. Collaborations
      • 8.3.4.4. Disease Type/Drug Class Launch
      • 8.3.4.5. Partnerships
      • 8.3.4.6. Others

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Cell Penetrating Peptide Market, by Region, 2018 - 2030 (USD Million)
  • Table 3 Global Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 Global Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 6 North America Cell Penetrating Peptide Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 8 North America Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 9 North America Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 12 U.S. Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 13 Canada Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 15 Canada Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 16 Europe Cell Penetrating Peptide Market, by Country, 2018 - 2030 (USD Million)
  • Table 17 Europe Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Europe Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 Europe Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 20 Germany Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 21 Germany Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 22 Germany Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 23 UK Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 24 UK Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 25 UK Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 26 France Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 France Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 28 France Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 29 Italy Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 30 Italy Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 31 Italy Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 32 Spain Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 33 Spain Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 34 Spain Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 35 Denmark Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 36 Denmark Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 37 Denmark Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 38 Sweden Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 39 Sweden Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 Sweden Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 41 Norway Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 42 Norway Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 43 Norway Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Cell Penetrating Peptide Market, by Country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 48 China Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 49 China Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 50 China Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 51 Japan Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 52 Japan Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 53 Japan Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 54 India Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 India Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 56 India Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 57 South Korea Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 58 South Korea Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 59 South Korea Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 60 Australia Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 61 Australia Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 62 Australia Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 63 Thailand Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 64 Thailand Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Thailand Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 66 Latin America Cell Penetrating Peptide Market, by Country, 2018 - 2030 (USD Million)
  • Table 67 Latin America Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Latin America Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 Latin America Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 70 Brazil Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 71 Brazil Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 72 Brazil Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 73 Mexico Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 74 Mexico Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 75 Mexico Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 77 Argentina Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 Argentina Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 83 South Africa Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 84 South Africa Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 85 South Africa Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 89 UAE Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 90 UAE Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 91 UAE Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Cell Penetrating Peptide Market Segmentation
  • Fig. 8 Market Snapshot, 2023
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 PESTEL Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Global Cell Penetrating Peptide Market: Disease Type Movement Analysis
  • Fig. 15 Global Cell Penetrating Peptide Market, by Protein-Derived CPPs, 2018 - 2030 (USD Million)
  • Fig. 16 Global Cell Penetrating Peptide Market, by Synthetic CPPs, 2018 - 2030 (USD Million)
  • Fig. 17 Global Cell Penetrating Peptide Market, by Chimeric CPPs, 2018 - 2030 (USD Million)
  • Fig. 18 Global Cell Penetrating Peptide Market: Application Movement Analysis
  • Fig. 19 Global Cell Penetrating Peptide Market, by Drug Delivery, 2018 - 2030 (USD Million)
  • Fig. 20 Global Cell Penetrating Peptide Market, by Gene Delivery 2018 - 2030 (USD Million)
  • Fig. 21 Global Cell Penetrating Peptide Market, by Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 22 Global Cell Penetrating Peptide Market, by Molecular Imaging 2018 - 2030 (USD Million)
  • Fig. 23 Global Cell Penetrating Peptide Market, by Others, 2018 - 2030 (USD Million)
  • Fig. 24 Global Cell Penetrating Peptide Market: End-use Movement Analysis
  • Fig. 25 Global Cell Penetrating Peptide Market, by Pharmaceutical and Biotechnology Company 2018 - 2030 (USD Million)
  • Fig. 26 Global Cell Penetrating Peptide Market, by Contract Research Organization (CROs) 2018 - 2030 (USD Million)
  • Fig. 27 Global Cell Penetrating Peptide Market, by Hospital and Clinics, 2018 - 2030 (USD Million)
  • Fig. 28 Global Cell Penetrating Peptide Market, by Others, 2018 - 2030 (USD Million)
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 Regional Outlook, 2023 & 2030
  • Fig. 31 Global Cell Penetrating Peptide Market: Region Movement Analysis
  • Fig. 32 North America Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 37 UK Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 38 France Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 43 Norway Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 45 Japan Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 46 China Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 47 India Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 48 Australia Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 58 UAE Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)